Philip Schneider

Philip J. Schneider, M.S., FASHP, FASPEN, FFIP, is founder and principal of MediHealthInsight, which provides onsultation to the industry and others on matters related to improving the use of medicines including the application of new technologies in healthcare.  He is also Chair, Alliance for Safe Biologic Medicines, International Advisory Board, which serves as an authoritative resource center of information for the public, as well as the healthcare and health policy communities, on the issues surrounding biologic medications. They provide information on the safety and quality of biologics, and seek solutions that ensure affordability and accessibility of biologic medications, while never compromising on patient safety. 
For 10 years he was Professor and Associate Dean for Academic and Professional Affairs for the University of Arizona, College of Pharmacy at the Phoenix Biomedical campus.  In this position, he was responsible for the launch and growth of the College of Pharmacy program at the new Phoenix Biomedical Campus.  He also held faculty appointments at the University of Arizona Colleges of Medicine and Public Health.

Before that, for 33 years he held positions at the Ohio State University including most recently Clinical Professor and Director of the Latiolais Leadership Program at the College of Pharmacy, The Ohio State University. 

He is a past president of the American Society of Health-System Pharmacists (ASHP) and member of the ASHP Visiting Leaders Program faculty, and past president of the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), having served for ten years as the first Editor-in-Chief of Nutrition in Clinical Practice, one of its two official publications.  He is currently a Vice President of the International Pharmaceutical Federation.

Professor Schneider serves on several Boards including the ARxIUM Scientific Advisory Board and PipelineRx Executive Advisory Board.